The pandemic is not just far from over — it is in a “critical moment where we are all under threat,” due to rising new variants and vaccine inequality, according to WHO spokesperson Dr. Margaret Harris.
, public health experts say. Yet the vast majority of the global population remains unvaccinated .
But a true end to the pandemic will likely only happen with the artificial immunity conferred by mass vaccination, according to Yanzhong Huang, a senior fellow for global health at the Council on Foreign Relations.A medical worker in a booth takes a nasal sample from a woman at a Coronavirus testing site in Seoul, South Korea, July 20, 2021.“You have countries that are making good progress toward building an immunity shield,” he told ABC News.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19: Health Trusts cancel surgeries as Covid admissions riseThe chief medical officer says the health service is operating under 'huge pressures'.
Read more »
Some people are seeking out a second dose of Covid-19 vaccine after getting J&J shotJason Gallagher, an infectious disease pharmacist in Philadelphia had gotten the Johnson & Johnson Covid-19 vaccine through a clinical trial in November, but this summer he didn't like the direction Covid-19 cases were taking due to variants.
Read more »
Pfizer Raises Full-Year Outlook on Covid-19 Vaccine SalesThe pharmaceutical company’s Covid-19 vaccine co-developed with BioNTech contributed $7.8 billion to Pfizer’s total sales of $18.98 billion in the latest quarter.
Read more »
LA County COVID-19 hospitalizations nearly double in 2 weeksLos Angeles County is seeing an uptick in COVID-19-related hospitalizations, with the number of patients nearly doubling over the last two weeks, health officials said.
Read more »
Pfizer data suggest third dose of Covid-19 vaccine 'strongly' boosts protection against Delta variantA third dose of the Pfizer/BioNTech Covid-19 vaccine can 'strongly' boost protection against the Delta variant -- beyond the protection afforded by the standard two doses, suggests new data released by Pfizer on Wednesday.
Read more »